Brief Description about the Project:
Despite the availability of flu vaccines for decades, influenza is still an important disease in both developing and developed countries with 500,000 casualties annually and many more people affected. From a global health perspective, the lack of effectivity, availability, affordability and accessibility of flu vaccines significantly limits our ability to respond to the seasonal flu every year and in the event of a pandemic. Currently, a low vaccine effectivity of 40% implies that 60% of vaccinated people are not sufficiently protected, with low confidence further contributing to limited uptake/immunization. In this project, public and private R&D organizations in India, EU and US collaborate on the development of two novel influenza vaccine concepts that meet the requirements of global vaccination, aiming to achieve <10% instead of 60% non-responders, lower costs, and better accessibility.
The first approach combines a low dose of a commercial, inactivated, seasonal flu vaccine with a novel, potent adjuvant, and will deliver proof-of-concept in Phase I and IIa trials within 5 years. The second approach builds on three innovations: 1) a novel recombinant HA with increased immunogenicity, 2) a potent
adjuvant, and 3) an easy, needle-free delivery by intradermal patches. Contra-productive parts of HA will be removed to increase the immunogenicity of neutralizing epitopes. The adjuvant further stimulates protective immunity and immunological memory. The use of intradermal patches opens possibilities for self-administration, which will improve vaccine uptake in developing as well as developed countries. With proven nonclinical immunogenicity and safety, we will embark on clinical development of this concept after completion of the project. These plans differ in complexity and timelines but are realistic with chances to deliver next-generation flu vaccines for the globe.
Project Associate - II
Position Starting: 15th November, 2023
No. of Vacancy: One
Employment status: Contract
Salary: Rs. 35000+24%HRA
Language: English
Experience: 2 Years experience in R&D in industrial and academic institutions or science and Technology organisations and scientific activities and services
Preferred Qualifications: Master’s degree in Natural Sciences or Bachelor’s Sciences in Engineering or Technology or Medicine from recognised University.
Scholars who are selected through National eligibility tests CSIR-UGC?NET including lectureship or GATE or selection process through National level examinations conducted by central government department and their agencies and institutions.
Location: Bangalore
Last Day for Receiving Application: 06th November 2023
Roles & Responsibilities:
Interested candidates may send their Resume to:The Principal Investigator
DBT INDIGO Project
SJMC
To Apply: E-mail cover letter and curriculum vitae with 3 references (names and email addresses / phone numbers) by on or before 06th November, 2023 yashashwini@sjri.res.in & cc to hr@sjri.res.in
For more information, please visit our website www.sjri.res.in
Can Contact us on the following Numbers 080-49467010/49467011/49467021